ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT BIESBROECK MD

Endocrinology, Diabetes Metabolism

7,054

$960K

677
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 50%

$136
Average prescription price

Avg: $147

JASJEET KAUR MD

Endocrinology, Diabetes Metabolism

4,867

$700K

480
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 50%

$144
Average prescription price

Avg: $147

GYAN BRARD MD

Endocrinology, Diabetes Metabolism

4,789

$658K

555
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$137
Average prescription price

Avg: $147

DINESHKUMAR PATEL MD

Endocrinology, Diabetes Metabolism

4,599

$661K

534
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$144
Average prescription price

Avg: $147

JONATHAN INSEL MD

Endocrinology, Diabetes Metabolism

4,468

$416K

401
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 50%

$93
Average prescription price

Avg: $147

ALEXANDER ZWART MD, FACP

Endocrinology, Diabetes Metabolism

4,245

$627K

504
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 50%

$148
Average prescription price

Avg: $147

MOMIN GABIR M.D.

Endocrinology, Diabetes Metabolism

4,195

$474K

342
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 50%

$113
Average prescription price

Avg: $147

SHAHZAD SHADMANY MD

Endocrinology, Diabetes Metabolism

3,894

$733K

663
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 50%

$188
Average prescription price

Avg: $147

SEEMA AHLUWALIA M.D.

Endocrinology, Diabetes Metabolism

3,730

$635K

580
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 50%

$170
Average prescription price

Avg: $147

KAREN BOX MD

Endocrinology, Diabetes Metabolism

3,671

$726K

361
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$198
Average prescription price

Avg: $147

DAVID ALSTER

Endocrinology, Diabetes Metabolism

3,410

$438K

462
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 50%

$129
Average prescription price

Avg: $147

ANDREA FERENCZI MD

Endocrinology, Diabetes Metabolism

3,313

$525K

548
490 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 50%

$158
Average prescription price

Avg: $147

DIANE GRONSKI MD

Endocrinology, Diabetes Metabolism

3,282

$589K

477
430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$179
Average prescription price

Avg: $147

ATUL LALANI M.D.

Endocrinology, Diabetes Metabolism

3,198

$351K

460
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$110
Average prescription price

Avg: $147

MITCHELL PARKER MD

Endocrinology, Diabetes Metabolism

2,932

$444K

348
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$151
Average prescription price

Avg: $147

JOAN BAILEY M.D.

Endocrinology, Diabetes Metabolism

2,839

$364K

267
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 50%

$128
Average prescription price

Avg: $147

PATRICIA GABRIEL DO

Endocrinology, Diabetes Metabolism

2,684

$365K

219
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$136
Average prescription price

Avg: $147

SATHYA JYOTHINAGARAM M.D.,

Endocrinology, Diabetes Metabolism

2,554

$396K

262
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 50%

$155
Average prescription price

Avg: $147

LORY BARAZ M.D.

Endocrinology, Diabetes Metabolism

2,457

$340K

303
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 50%

$138
Average prescription price

Avg: $147

MANJU SCHORR M.D.

Endocrinology, Diabetes Metabolism

2,426

$260K

213
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 50%

$107
Average prescription price

Avg: $147

HYUN SUK CHONG MD

Endocrinology, Diabetes Metabolism

2,320

$349K

296
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$150
Average prescription price

Avg: $147

REKHA KUMARI AGARWAL MD

Endocrinology, Diabetes Metabolism

2,113

$396K

336
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 50%

$187
Average prescription price

Avg: $147

PHILIP LEVY M.D.

Endocrinology, Diabetes Metabolism

2,105

$374K

234
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 50%

$178
Average prescription price

Avg: $147

ABDULLAH HANNA-MOUSSA MD

Endocrinology, Diabetes Metabolism

2,081

$396K

314
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 50%

$191
Average prescription price

Avg: $147

MURUGASU NAGUL MD

Endocrinology, Diabetes Metabolism

1,877

$196K

292
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 50%

$104
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank